Effectiveness of Using Tobacco Free Snuff in Reducing Negative Effects of Smokeless Tobacco Use
NCT00218270 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 138
Last updated 2017-01-10
Summary
Though spit tobacco is smokeless, it still affects the cardiovascular system and may be associated with heart disease, stroke, and high blood pressure. Long-term effects of smokeless tobacco (ST) include tooth abrasion, gum recession, mouth disease, loss of bone in the jaw, yellowing of teeth, and chronic bad breath. This study will assess the effectiveness of using tobacco free snuff in reducing levels of exposure to tobacco and associated toxicity, as well as enhancing motivation to either quit or sustain lower levels of nicotine intake.
Conditions
- Tobacco Use Disorder
Interventions
- DRUG
-
Tobacco free snuff
Tobacco free snuff
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
lead NIH
Principal Investigators
-
Dorothy Hatsukami, PhD · University of Minnesota
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2002-12-31
- Primary Completion
- 2005-05-31
- Completion
- 2005-05-31
Countries
- United States
Study Locations
More Related Trials
-
Project 1, Study 2: The Combined Impact of Nicotine Replacement and Spectrum Cigarettes
NCT02301325 ·Status: COMPLETED ·Phase: NA
-
Identifying Treatments to Motivate Smokers to Quit
NCT01122238 ·Status: COMPLETED ·Phase: PHASE4
-
Post-Market Surveillance of Tobacco Products
NCT04255459 ·Status: COMPLETED ·Phase: NA
-
Assessing the Use of Nicotine Gum to Decrease Betel Nut Chewing in Saipan
NCT05758298 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Cessation in Non-Daily Smokers
NCT02168855 ·Status: COMPLETED ·Phase: NA
-
Free Samples for Health
NCT05627596 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Informing Tobacco Treatment Guidelines for African American Non-Daily Smokers
NCT02244918 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluating the Impact of Synthetic Cooling Agents in Combustible Cigarettes on Smoking Perceptions and Use
NCT06230159 ·Status: COMPLETED ·Phase: NA
-
Telephone Counseling for Snuff Users
NCT00265681 ·Status: COMPLETED ·Phase: NA
-
Tobacco Cessation: Treatment Delivery and Predictors of Outcome
NCT01859364 ·Status: WITHDRAWN
-
Project 2: Strategies for Reducing Nicotine Content in Cigarettes
NCT02139930 ·Status: COMPLETED ·Phase: NA
-
Cooling Agent Pilot Among Adult Menthol Smokers
NCT06477601 ·Status: COMPLETED ·Phase: NA
-
Novel Determinants and Measures of Smokeless Tobacco Use: Study 2
NCT01067599 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Reducing Smoking in Facilitating Smoking Cessation in Adolescents - 2
NCT00158158 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Examination of Sleep, Smoking Cessation, and Cardiovascular Health
NCT02941718 ·Status: COMPLETED ·Phase: PHASE3
-
Preventing Relapse Following Involuntary Smoking Abstinence
NCT01374724 ·Status: UNKNOWN ·Phase: NA
-
Identifying Optimal Smoking Cessation Intervention Components (Cessation)
NCT01116986 ·Status: COMPLETED ·Phase: PHASE4
-
Very-Low Nicotine Cigarettes and Non-Daily Smokers
NCT02228824 ·Status: COMPLETED ·Phase: NA
-
Project 1, Study 1: Investigating the Impact of Nicotine Using Spectrum Cigarettes
NCT01681875 ·Status: COMPLETED ·Phase: NA
-
Novel Determinants and Measures of Smokeless Tobacco Use: Study 1
NCT01067586 ·Status: COMPLETED
-
Smartphone Application for Smoking Cessation
NCT02134509 ·Status: COMPLETED ·Phase: NA
-
Snuff Use, Smoking, Periodontitis and Mortality: 30-year Cohort Study From Sweden
NCT03918902 ·Status: COMPLETED
-
De-nicotinised Cigarettes Study
NCT01250301 ·Status: COMPLETED ·Phase: NA
-
Evaluating and Improving the Sustainability of State-level Tobacco Control Programs in the United States
NCT03598114 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study to Evaluate the Efficacy of Ariva® Silver Wintergreen, a Smoking Aversive Lozenge
NCT01336816 ·Status: COMPLETED ·Phase: PHASE1